FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)

Status: current, Primitive. Date: 31-Jan 2002. Module: SNOMED CT model component

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Case sensitive SNOMED CT model component
900000000001157018 REPLACED BY association reference set en Synonym Active Case sensitive SNOMED CT model component

131244 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set Is a Historical association true Inferred relationship Some
Members associationTargetComponent
pancreatic extract 10 000 units modified release capsule, 100 lipase 10 000 units + amylase 8000 units + protease 600 units enteric capsule, 100
pancreatic extract 25 000 units modified release capsule lipase 25 000 units + amylase 18 000 units + protease 1000 units enteric capsule
pancreatic extract 25 000 units modified release capsule, 100 lipase 25 000 units + amylase 18 000 units + protease 1000 units enteric capsule, 100
pancreatic extract 40 000 units modified release capsule lipase 40 000 units + amylase 25 000 units + protease 1600 units enteric capsule
pancreatic extract 40 000 units modified release capsule, 100 lipase 40 000 units + amylase 25 000 units + protease 1600 units enteric capsule, 100
pancreatic extract 5000 units/100 mg enteric coated granules lipase 5000 units/100 mg + amylase 3600 units/100 mg + protease 200 units/100 mg enteric coated granules
pancreatic extract 5000 units/100 mg enteric coated granules, 20 g lipase 5000 units/100 mg + amylase 3600 units/100 mg + protease 200 units/100 mg enteric coated granules, 20 g
pancreatic extract 5000 units modified release capsule lipase 5000 units + amylase 4000 units + protease 300 units enteric capsule
pancreatic extract 5000 units modified release capsule, 100 lipase 5000 units + amylase 4000 units + protease 300 units enteric capsule, 100
pancrelipase lipase + amylase + protease
pancrelipase 25 000 units capsule lipase 25 000 units + amylase 22 500 units + protease 1250 units enteric capsule
pancrelipase 25 000 units capsule, 100 lipase 25 000 units + amylase 22 500 units + protease 1250 units enteric capsule, 100
paper wasp venom paper wasp venom
paper wasp venom paper wasp venom
paper wasp venom 550 microgram injection, vial paper wasp venom 550 microgram injection, vial
para-aminohippuric acid Para-aminohippuric acid
phenylephrine hydrochloride 12.2 mg + paracetamol 1 g powder, 1 sachet phenylephrine hydrochloride 12.2 mg + paracetamol 1 g powder for oral liquid, 1 sachet
phenylephrine hydrochloride 12.2 mg + paracetamol 1 g powder, 10 sachets phenylephrine hydrochloride 12.2 mg + paracetamol 1 g powder for oral liquid, 10 sachets
paracetamol 600 mg powder for oral liquid, 1 sachet paracetamol 600 mg powder for oral liquid, sachet
paracetamol 600 mg powder for oral liquid, 10 sachets paracetamol 600 mg powder for oral liquid, 10 sachets
paracetamol 600 mg powder for oral liquid, 5 sachets paracetamol 600 mg powder for oral liquid, 5 sachets
pasireotide pasireotide embonate
pasireotide 20 mg modified release injection, vial pasireotide (as embonate) 20 mg modified release injection, vial
pasireotide 300 microgram/mL injection, ampoule pasireotide (as diaspartate) 300 microgram/mL injection, ampoule
pasireotide 300 microgram/mL injection, 60 x 1 mL ampoules pasireotide (as diaspartate) 300 microgram/mL injection, 60 x 1 mL ampoules
pasireotide 40 mg modified release injection, vial pasireotide (as embonate) 40 mg modified release injection, vial
pasireotide 60 mg modified release injection, vial pasireotide (as embonate) 60 mg modified release injection, vial
pasireotide 600 microgram/mL injection, ampoule pasireotide (as diaspartate) 600 microgram/mL injection, ampoule
pasireotide 600 microgram/mL injection, 60 x 1 mL ampoules pasireotide (as diaspartate) 600 microgram/mL injection, 60 x 1 mL ampoules
pasireotide 900 microgram/mL injection, ampoule pasireotide (as diaspartate) 900 microgram/mL injection, ampoule
pasireotide 900 microgram/mL injection, 60 x 1 mL ampoules pasireotide (as diaspartate) 900 microgram/mL injection, 60 x 1 mL ampoules
peginterferon alfa-2b 100 microgram injection, cartridge peginterferon alfa-2b 100 microgram injection, chamber
peginterferon alfa-2b 120 microgram injection, cartridge peginterferon alfa-2b 120 microgram injection, chamber
peginterferon alfa-2b 150 microgram injection, cartridge peginterferon alfa-2b 150 microgram injection, chamber
peginterferon alfa-2b 50 microgram injection, cartridge peginterferon alfa-2b 50 microgram injection, chamber
peginterferon alfa-2b 80 microgram injection, cartridge peginterferon alfa-2b 80 microgram injection, chamber
peginterferon beta-1a 125 microgram / 0.5 mL injection, 0.5 mL injection device (medicinal product unit of use) Unknown Cell Type 2
peginterferon beta-1a 125 microgram / 0.5 mL injection, 2 x 0.5 mL injection devices (medicinal product pack) Unknown Cell Type 2
peginterferon beta-1a 125 microgram/0.5 mL injection, 2 x 0.5 mL injection devices Unknown Cell Type 2
peginterferon beta-1a 125 microgram/0.5 mL injection, injection device Unknown Cell Type 2
peginterferon beta-1a 63 microgram / 0.5 mL injection [1 x 0.5 mL injection device] (&) peginterferon beta-1a 94 microgram / 0.5 mL injection [1 x 0.5 mL injection device], 1 pack (medicinal product pack) Unknown Cell Type 2
peginterferon beta-1a 63 microgram / 0.5 mL injection, 0.5 mL injection device (medicinal product unit of use) Unknown Cell Type 2
peginterferon beta-1a 63 microgram / 0.5 mL injection, 1 x 0.5 mL injection device (medicinal product pack) Unknown Cell Type 2
peginterferon beta-1a 63 microgram/0.5 mL injection [0.5 mL injection device] (&) peginterferon beta-1a 94 microgram/0.5 mL injection [0.5 mL injection device], 1 pack Unknown Cell Type 2
peginterferon beta-1a 63 microgram/0.5 mL injection, 0.5 mL injection device Unknown Cell Type 2
peginterferon beta-1a 63 microgram/0.5 mL injection, injection device Unknown Cell Type 2
peginterferon beta-1a 94 microgram / 0.5 mL injection, 0.5 mL injection device (medicinal product unit of use) Unknown Cell Type 2
peginterferon beta-1a 94 microgram / 0.5 mL injection, 1 x 0.5 mL injection device (medicinal product pack) Unknown Cell Type 2
peginterferon beta-1a 94 microgram/0.5 mL injection, 0.5 mL injection device Unknown Cell Type 2
peginterferon beta-1a 94 microgram/0.5 mL injection, injection device Unknown Cell Type 2
pentastarch + sodium chloride hydroxyethyl starch 130/0.4 + sodium chloride
pentastarch 6% (30 g/500 mL) + sodium chloride 0.9% (4.5 g/500 mL) injection, 10 x 500 mL bags hydroxyethyl starch 130/0.4 6% (60 g/L) + sodium chloride 0.9% (9 g/L) injection, 10 x 500 mL bags
pentastarch 6% (30 g/500 mL) + sodium chloride 0.9% (4.5 g/500 mL) injection, 10 x 500 mL bottles hydroxyethyl starch 130/0.4 6% (60 g/L) + sodium chloride 0.9% (9 g/L) injection, 10 x 500 mL bottles
pentastarch 6% (30 g/500 mL) + sodium chloride 0.9% (4.5 g/500 mL) injection, 15 x 500 mL bags hydroxyethyl starch 130/0.4 6% (60 g/L) + sodium chloride 0.9% (9 g/L) injection, 15 x 500 mL bags
pentastarch 6% (30 g/500 mL) + sodium chloride 0.9% (4.5 g/500 mL) injection, 20 x 500 mL bags hydroxyethyl starch 130/0.4 6% (60 g/L) + sodium chloride 0.9% (9 g/L) injection, 20 x 500 mL bags
pentastarch 6% (30 g/500 mL) + sodium chloride 0.9% (4.5 g/500 mL) injection, bag hydroxyethyl starch 130/0.4 6% (60 g/L) + sodium chloride 0.9% (9 g/L) injection, 500 mL bag
pentastarch 6% (30 g/500 mL) + sodium chloride 0.9% (4.5 g/500 mL) injection, bottle hydroxyethyl starch 130/0.4 6% (60 g/L) + sodium chloride 0.9% (9 g/L) injection, 500 mL bottle
perfusion solution solution
zinc + phenylephrine zinc sulfate + phenylephrine
phenylephrine hydrochloride 0.25% + chlorhexidine gluconate 0.3% nasal cream Unknown Cell Type 2
phenylephrine hydrochloride 0.25% + chlorhexidine gluconate 0.3% nasal cream, 15 g Unknown Cell Type 2
picosulfate sodium monohydrate 10 mg + magnesium carbonate hydrate 7.87 g + citric acid 11.81 g powder for oral liquid, 2 x 20 g sachets Unknown Cell Type 2
picosulfate sodium monohydrate 10 mg + magnesium carbonate hydrate 7.87 g + citric acid 11.81 g powder for oral liquid, 20 g sachet Unknown Cell Type 2
picosulfate sodium monohydrate 10 mg + magnesium carbonate hydrate 7.87 g + citric acid 11.81 g powder for oral liquid, 20 x 20 g sachets Unknown Cell Type 2
picosulfate sodium monohydrate 7.5 mg / 1 mL oral liquid, 1 mL drop (medicinal product unit of use) Unknown Cell Type 2
picosulfate sodium monohydrate 7.5 mg / 1 mL oral liquid, 15 mL (medicinal product pack) Unknown Cell Type 2
picosulfate sodium monohydrate 7.5 mg / 1 mL oral liquid, 30 mL (medicinal product pack) Unknown Cell Type 2
picosulfate sodium monohydrate 7.5 mg/mL oral liquid, 15 mL Unknown Cell Type 2
picosulfate sodium monohydrate 7.5 mg/mL oral liquid, 30 mL Unknown Cell Type 2
picosulfate sodium monohydrate 7.5 mg/mL oral liquid, drop Unknown Cell Type 2
pyrethrin I 0.175% + pyrethrin II 0.175% + piperonyl butoxide 1.75% application piperonyl butoxide 1.75% + pyrethrin I 0.175% + pyrethrin II 0.175% foam
pyrethrin I 0.175% + pyrethrin II 0.175% + piperonyl butoxide 1.75% application, 100 mL piperonyl butoxide 1.75% + pyrethrin I 0.175% + pyrethrin II 0.175% foam, 100 mL
plerixafor 24 mg/1.2 mL subcutaneous infusion injection, 1.2 mL vial plerixafor 24 mg/1.2 mL injection, 1.2 mL vial
plerixafor 24 mg/1.2 mL subcutaneous infusion injection, vial plerixafor 24 mg/1.2 mL injection, vial
pneumococcal 7 valent conjugate vaccine pneumococcal 7 valent conjugate vaccine
pneumococcal 7 valent conjugate vaccine 16 microgram/0.5 mL injection, syringe pneumococcal 7 valent conjugate vaccine injection, 0.5 mL syringe
pneumococcal 7 valent conjugate vaccine 16 microgram/0.5 mL injection, 0.5 mL syringe pneumococcal 7 valent conjugate vaccine injection, 0.5 mL syringe
pneumococcal 7 valent conjugate vaccine 16 microgram/0.5 mL injection, 10 x 0.5 mL syringes pneumococcal 7 valent conjugate vaccine injection, 10 x 0.5 mL syringes
pneumococcal 13 valent polysaccharide conjugate vaccine pneumococcal 13 valent conjugate vaccine
pneumococcal 13 valent polysaccharide conjugate vaccine 30.8 microgram/0.5 mL injection, syringe pneumococcal 13 valent conjugate vaccine injection, 0.5 mL syringe
pneumococcal 13 valent polysaccharide conjugate vaccine 30.8 microgram/0.5 mL injection, 0.5 mL syringe pneumococcal 13 valent conjugate vaccine injection, 0.5 mL syringe
pneumococcal 13 valent polysaccharide conjugate vaccine 30.8 microgram/0.5 mL injection, 10 x 0.5 mL syringes pneumococcal 13 valent conjugate vaccine injection, 10 x 0.5 mL syringes
pneumococcal 10 valent polysaccharide conjugate vaccine pneumococcal 10 valent conjugate vaccine
pneumococcal 10 valent polysaccharide conjugate vaccine 16 microgram injection, 0.5 mL syringe pneumococcal 10 valent conjugate vaccine injection, 0.5 mL syringe
pneumococcal 10 valent polysaccharide conjugate vaccine 16 microgram injection, 0.5 mL syringe pneumococcal 10 valent conjugate vaccine injection, 0.5 mL syringe
pneumococcal 10 valent polysaccharide conjugate vaccine 16 microgram injection, 10 x 0.5 mL syringes pneumococcal 10 valent conjugate vaccine injection, 10 x 0.5 mL syringes
pneumococcal purified capsular polysaccharides pneumococcal 23 valent vaccine
pneumococcal purified capsular polysaccharides 25 microgram/0.5 mL injection, syringe pneumococcal 23 valent vaccine injection, 0.5 mL syringe
pneumococcal purified capsular polysaccharides 25 microgram / 0.5 mL injection, 0.5 mL vial (medicinal product unit of use) pneumococcal 23 valent vaccine injection, 0.5 mL vial
pneumococcal purified capsular polysaccharides 25 microgram/0.5 mL injection, 0.5 mL syringe pneumococcal 23 valent vaccine injection, 0.5 mL syringe
pneumococcal purified capsular polysaccharides 25 microgram/0.5 mL injection, 0.5 mL vial pneumococcal 23 valent vaccine injection, 0.5 mL vial
pneumococcal purified capsular polysaccharides 25 microgram/0.5 mL injection, 10 x 0.5 mL syringes pneumococcal 23 valent vaccine injection, 10 x 0.5 mL syringes
podophyllotoxin 0.5% application podophyllotoxin 0.5% solution
podophyllotoxin 0.5% application, 3 mL podophyllotoxin 0.5% solution, 3 mL
poliomyelitis virus type 1 (Mahoney) inactivated vaccine poliovirus type 1 inactivated antigen
poliomyelitis virus type 1 (Mahoney) inactivated vaccine + poliomyelitis virus type 2 (MEF1) inactivated vaccine + poliomyelitis virus type 3 (Saukett) inactivated vaccine polio trivalent inactivated vaccine
poliomyelitis virus type 1 (Mahoney) inactivated vaccine 40 D antigen units + poliomyelitis virus type 2 (MEF1) inactivated vaccine 8 D antigen units + poliomyelitis virus type 3 (Saukett) inactivated vaccine 32 D antigen units injection, 0.5 mL syringe polio trivalent inactivated vaccine injection, 0.5 mL syringe
poliomyelitis virus type 1 (Mahoney) inactivated vaccine 40 D antigen units + poliomyelitis virus type 2 (MEF1) inactivated vaccine 8 D antigen units + poliomyelitis virus type 3 (Saukett) inactivated vaccine 32 D antigen units injection, 0.5 mL syringe polio trivalent inactivated vaccine injection, 0.5 mL syringe
poliomyelitis virus type 1 (Mahoney) inactivated vaccine 40 D antigen units + poliomyelitis virus type 2 (MEF1) inactivated vaccine 8 D antigen units + poliomyelitis virus type 3 (Saukett) inactivated vaccine 32 D antigen units injection, 10 x 0.5 mL syringes polio trivalent inactivated vaccine injection, 10 x 0.5 mL syringes
poliomyelitis virus type 1 (Sabin strain (LS-c, 2ab)) live attenuated oral vaccine poliovirus type 1 live antigen
poliomyelitis live attenuated oral vaccine polio trivalent live vaccine

Start Previous Page 1309 of 1313 Next End

Reference Sets

Australian dialect reference set

Unit of use quantity reference set

Reference set descriptor

Back to Start